These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 18679556

  • 61. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
    Meltzer EO, Lockey RF, Friedman BF, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Propionate Clinical Research Study Group.
    Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
    [Abstract] [Full Text] [Related]

  • 62. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler.
    Lundback B, Alexander M, Day J, Hebert J, Holzer R, Van Uffelen R, Kesten S, Jones AL.
    Respir Med; 1993 Nov; 87(8):609-20. PubMed ID: 8290745
    [Abstract] [Full Text] [Related]

  • 63. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate.
    Wong JY, Zacharin MR, Hocking N, Robinson PJ.
    J Paediatr Child Health; 2002 Feb; 38(1):59-62. PubMed ID: 11869402
    [Abstract] [Full Text] [Related]

  • 64. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
    Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T.
    J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
    [Abstract] [Full Text] [Related]

  • 65. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP, Bateman ED, Voves R, Müller T, Wolf S, Engelstätter R.
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [Abstract] [Full Text] [Related]

  • 66. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L, Pedersen S.
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [Abstract] [Full Text] [Related]

  • 67. Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma.
    Bateman ED, Bantje TA, João Gomes M, Toumbis MG, Huber RM, Naya I, Eliraz A.
    Am J Respir Med; 2003 Jun; 2(3):275-81. PubMed ID: 14720008
    [Abstract] [Full Text] [Related]

  • 68. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [Abstract] [Full Text] [Related]

  • 69. Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older.
    Raphael G, Yiu G, Sakov A, Liu S, Caracta C.
    J Asthma; 2018 Jun; 55(6):640-650. PubMed ID: 28763243
    [Abstract] [Full Text] [Related]

  • 70. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ, Wilson AM, Coutie WJ, Lipworth BJ.
    Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
    [Abstract] [Full Text] [Related]

  • 71. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
    Kim K, Quesada J, Szmaydy-Rikken N, Darken P, Shah T.
    J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
    [Abstract] [Full Text] [Related]

  • 72. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
    Muley P, Shah M, Muley A.
    Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
    [Abstract] [Full Text] [Related]

  • 73. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
    Ställberg B, Pilman E, Skoogh BE, Hermansson BA.
    Respir Med; 2007 Mar; 101(3):610-5. PubMed ID: 16889952
    [Abstract] [Full Text] [Related]

  • 74. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Nielsen LP, Dahl R.
    Am J Respir Crit Care Med; 2000 Jun; 161(6):2114-5. PubMed ID: 10852798
    [No Abstract] [Full Text] [Related]

  • 75. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 Jun; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 76. Salmeterol/fluticasone propionate combination.
    Spencer CM, Jarvis B.
    Drugs; 1999 Jun; 57(6):933-40; discussion 941-3. PubMed ID: 10400406
    [Abstract] [Full Text] [Related]

  • 77. Inhaled fluticasone propionate for chronic asthma.
    Adams N, Bestall J, Jones PW.
    Cochrane Database Syst Rev; 2001 Jun; (3):CD003135. PubMed ID: 11687040
    [Abstract] [Full Text] [Related]

  • 78. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
    Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
    [Abstract] [Full Text] [Related]

  • 79. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A.
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [Abstract] [Full Text] [Related]

  • 80. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B, Faulds D.
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.